ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+5.74%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
Cap. Flow
-$6.1M
Cap. Flow %
-4.52%
Top 10 Hldgs %
95.53%
Holding
15
New
1
Increased
4
Reduced
4
Closed
2

Top Buys

1
BCYC
Bicycle Therapeutics
BCYC
$7.42M
2
GLPG icon
Galapagos
GLPG
$3.22M
3
PRQR icon
ProQR Therapeutics
PRQR
$2.39M
4
SPRO icon
Spero Therapeutics
SPRO
$1.15M
5
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$1.13M

Top Sells

1
ARWR icon
Arrowhead Research
ARWR
$11.3M
2
SYBX icon
Synlogic
SYBX
$3.21M
3
BPMC
Blueprint Medicines
BPMC
$2.45M
4
FATE icon
Fate Therapeutics
FATE
$1.93M
5
MRUS icon
Merus
MRUS
$1.46M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QURE icon
1
uniQure
QURE
$896M
$28.5M 9.89%
364,596
– –
MRUS icon
2
Merus
MRUS
$4.98B
$20.4M 7.08%
1,391,497
-100,000
-7% -$1.46M
ARWR icon
3
Arrowhead Research
ARWR
$3.05B
$14.8M 5.13%
557,455
-425,000
-43% -$11.3M
SPRO icon
4
Spero Therapeutics
SPRO
$116M
$13.3M 4.61%
1,154,356
+100,000
+9% +$1.15M
FATE icon
5
Fate Therapeutics
FATE
$120M
$12.2M 4.24%
602,096
-95,000
-14% -$1.93M
SYBX icon
6
Synlogic
SYBX
$17M
$9.5M 3.3%
1,043,922
-353,094
-25% -$3.21M
XENE icon
7
Xenon Pharmaceuticals
XENE
$2.98B
$9.38M 3.26%
951,527
– –
BCYC
8
Bicycle Therapeutics
BCYC
$511M
$7.42M 2.58%
+737,529
New +$7.42M
PVLA
9
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$6.82M 2.37%
1,451,850
+241,013
+20% +$1.13M
PRQR icon
10
ProQR Therapeutics
PRQR
$237M
$6.82M 2.37%
748,861
+262,163
+54% +$2.39M
GLPG icon
11
Galapagos
GLPG
$2.07B
$6.04M 2.1%
46,840
+25,000
+114% +$3.22M
BPMC
12
DELISTED
Blueprint Medicines
BPMC
– –
-30,618
Closed -$2.45M
CTMX icon
13
CytomX Therapeutics
CTMX
$336M
– –
-101,767
Closed -$1.09M
IBB icon
14
iShares Biotechnology ETF
IBB
$5.6B
– –
0
– –
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –